Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
XOMA 052 in Type 2 Diabetes on Metformin
NCT01066715Phase 2Completed
- Sponsor
- XOMA
- Start
- Jan 2010
- Primary completion
- Jul 2011
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of gevokizumab in type 2 diabetes mellitus (T2DM), sponsored by XOMA. Started Jan 2010; status: completed.
02
Drugs
gevokizumab
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT01066715.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01066715.